-
Those of you who know me know that I’ve been a huge advocate for generic prescriptions since the early part of my PBM/pharmacy career in 2001. It wasn’t long ago that I talked about unresponsible reporting when slamming generics and scaring the population. But, we all enjoy a good conspiracy...
Posted to
News
by
Enabling Healthy Decisions
on
Wed, May 22 2013
Filed under:
Filed under: Healthcare, Pharma, PBM / Pharmacy, Books / Articles, Value Propositions, Marketing / Communications, Rx, pharmacy, PBM, generic drugs
-
>Generic drugs have been an effective cost containment solution for traditional, small molecule pharmaceuticals. As large molecule biologics proliferate and take up a growing share of medical spending, we also increasingly need cost containment. The path we’re on now in the US and Europe is...
-
Having to endure an encounter with another dreary batch of lifeless communications about ‘multi-channel marketing’, ‘patient strategies’, and ‘market access’ isn’t the way that anyone working in the pharmaceutical industry wants to begin their day. Nevertheless...
-
As this activity comparison of the last seven days’ conversation on Twitter concerning the pharmaceutical industry demonstrates, you can use hashtags other than #pharma if you want — but don’t expect anyone to discover and read what you post. (Analytics c/o Symplur) Tagged: pharma,...
-
Medication mix-up’s are a well-known source of errors and harm in the hospital. So we shouldn’t be surprised that similar errors occur in other settings, including the home. Medication Errors in the Home: A Multisite Study of Children With Cancer in the journal Pediatrics documents the high...
-
While we are generally a society focused on innovation from start-ups (and now all the incubators like Rock Health), there are a few big companies that are able to innovate while growing. That’s not always easy and companies often need some catalyst to make this happen. Right now, there are four...
Posted to
News
by
Enabling Healthy Decisions
on
Sun, Apr 28 2013
Filed under:
Filed under: Healthcare, incentives, HIT, Innovation, Technology, Pharma, ACO, exercise, PBM / Pharmacy, Managed Care, Books / Articles, Value Propositions, Marketing / Communications, Leadership, Consumerism, Press, mHealth, Walgreens, Care Management, PBMI, QuantifiedSelf, $WAG
-
It’s hard for policy wonks, politicians or health plans to be viewed credibly when promoting health care cost containment. Discussion quickly turns to “rationing,” and “death panels,” which no one wants to be associated with, and as a result the federal government has done...
-
USA Today has a full page article on the rise of heroin addiction in the suburbs, but adds absolutely nothing to what’s already widely known. (See, for example, my post on the topic from early 2012.) Teens and adults start by abusing the painkiller oxycontin, which is available by prescription...
-
Pharmaceutical Benefits Manager (PBM) Express Scripts released a report claiming that more than $400B in annual pharmacy expenditures are wasted and that the greatest waste occurs in the poorest states, i.e., the South. The map is pretty striking with the North the best, middle next, and South the worst...
-
Treato, an Israeli company that scours thousands of social media sites to glean patient insights about pharmaceuticals and treatments, has landed $14.5 million in new capital. OrbiMed Israel Partners and New Leaf Venture Partners led the round of funding, which also included previous investors Reed Elsevier...
Posted to
News
by
mobihealthnews
on
Wed, Apr 24 2013
Filed under:
Filed under: Uncategorized, Pharma, Pharmaceuticals, data mining, New Leaf Venture Partners, data analytics, OrbiMed Israel Partners, Treato Pharma, Western Technology Investments, Treato, Reed Elsevier Ventures
-
Google’s former Chief Health Strategist Roni Zeiger MD and Gilles Frydman, founder of the Association of Cancer Online Resources (ACOR), announced the launch of Smart Patients, a new online community for cancer patients and caregivers, at the TEDMED event in Washington DC last week.
“What...
Posted to
News
by
mobihealthnews
on
Tue, Apr 23 2013
Filed under:
Filed under: Uncategorized, Pharma, Google Health, Participatory Medicine, clinical trials, TedMed, smart patients, Biotech, ACOR, patient community, Association Cancer Online Resources, cancer community
-
A reader made an interesting comment on an old post, so I’m highlighting it here in the hopes that more might see it. Anyone heard about this? “Has Genenetch looked into the practice of retinal specialists multi-dosing Lucentis, i.e., administering up to 4 doses, from a single use vial? Some...
-
This is the transcript of yesterday’s podcast with Castlight Health President John Driscoll. David E. Williams: This is David Williams from the Health Business Group. I’m speaking today with John Driscoll, president of Castlight Health. John, nice to speak with you today. John...
-
Health care transparency leader Castlight Health has launched a tool to manage pharmacy costs and signed its first deal with a health plan: Harvard Pilgrim. In this podcast interview, Castlight president John Driscoll and I discuss: What the new pharmacy tool adds to the offerings already on the market...
-
In Europe, reimbursement decisions for drugs often include explicit consideration of cost effectiveness and a comparison of the efficacy of the new drug with products that are already available. In the US, such considerations are excluded, at least for Medicare, which is the biggest payer. In the latest...